Survival and PSA relapse data after hypofiractionated radiotherapy for early stage prostate cancer

Survival and PSA relapse data after hypofiractionated radiotherapy for early stage prostate cancer

Bibliographic Details
Main Authors:	Law, A, Higgins, G, Kerr, G, Mclaren, D, Howard, G
Format:	Conference item
Published:	2007

Similar Items

Improved Outcomes With Dose Escalated Hypofractionated Radiotherapy for Prostate Cancer
by: Mackenzie, J, et al.
Published: (2011)

Outcome analysis of 300 prostate cancer patients treated with neoadjuvant androgen deprivation and hypofractionated radiotherapy.
by: Higgins, G, et al.
Published: (2006)

Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis
by: Narisa Dewi Maulany Darwis, et al.
Published: (2020-08-01)

Quantitative PSA RT-PCR for preoperative staging of prostate cancer.
by: Kurek, R, et al.
Published: (2003)

Cyclooxygenase-2 inhibitors delay relapse and reduce Prostate Specific Antigen (PSA) velocity in patients treated with radiotherapy for nonmetastatic prostate cancer: a pilot study
by: Liam King, et al.
Published: (2020-03-01)

Pre-radiotherapy PSA Level as a Predictor for Biochemical Control in Prostate Cancer Patients Receiving Radiotherapy after Radical Prostatectomy
by: Din-Li Tsan, et al.
Published: (2013-04-01)

<sup>68</sup>Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
by: Finn Edler von Eyben, et al.
Published: (2021-03-01)

Blood levels of free-PSA but not complex-PSA significantly correlates to prostate release of PSA in semen in young men, while blood levels of complex-PSA, but not free-PSA increase with age.
by: Sävblom, C, et al.
Published: (2005)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
by: Naseruddin Höti, et al.
Published: (2023-02-01)

Modeled Early Longitudinal PSA Kinetics Prognostic Value in Rising PSA Prostate Cancer Patients after Local Therapy Treated with ADT +/− Docetaxel
by: Aurore Carrot, et al.
Published: (2022-02-01)

Role of hK2, free PSA, and complexed PSA measurements in the very early detection of prostate cancer.
by: Lilja, H
Published: (2001)

Pre-radiotherapy PSA level as a predictor
by: Viroj Wiwanitkit
Published: (2013-08-01)

Prostate-speciﬁc antigen response after Abiraterone treatment in mCRPC: PSA as a predictor of overall survival
by: Alexandre Mendonça Macedo, et al.
Published: (2023-02-01)

Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer
by: Katz Alan, et al.
Published: (2012-11-01)

Management of a localized prostatic adenocarcinoma despite the very high rate of PSA and the large tumor mass: Does PSA level indicate the stage of prostate cancer?
by: Hammou el Farhaoui, et al.
Published: (2023-10-01)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
by: Törnblom, M, et al.
Published: (2001)

The effect on the sensitivities of PSA and PSA-age volume score of IPSS and nocturia in predicting positive prostate biopsy findings
by: O. Üçer, et al.
Published: (2017-06-01)

Relation between Serum Level of Total PSA and Free PSA/Total PSA Ratio with Grade of Prostate Cancer
by: Mohammad Yazdani, et al.
Published: (2013-10-01)

Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA.
by: Sävblom, C, et al.
Published: (2009)

CUT-OFF POINT OF PSA AND PSA DENSITY IN PROSTATE CANCER SUSPECTED PATIENTS
by: Daniel Simanjuntak, et al.
Published: (2016-03-01)

Salvage Radiotherapy for Relapsed Prostate Cancer after Radical Prostatectomy Is Associated with Normal Life Expectancy
by: Gunnar Lohm, et al.
Published: (2024-01-01)

Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study.
by: Burton, A, et al.
Published: (2013)

Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee.
by: Blijenberg, BG, et al.
Published: (2003)

Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer
by: Rie von Eyben, et al.
Published: (2023-08-01)

THE PROGNOSTIC VALUE OF BASELINE PSA BLOOD IN THE TREATMENT OF PROSTATE CANCER
by: A. A. Gritskevich, et al.
Published: (2017-02-01)

Prostate cancer: estimating the benefits of PSA screening.
by: Vickers, A, et al.
Published: (2009)

PROSTATE CANCER WITH A HIGH BASELINE PSA LEVEL AFTER COMBINED TREATMENT
by: A. T. Asratov, et al.
Published: (2017-12-01)

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT
by: Hamdy, FC, et al.
Published: (2020)

Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer
by: Hyungseok Cho, et al.
Published: (2022-03-01)

Diagnostic value of free-to-total PSA proportion and PSA density in prostate cancer detection for prostate volumes >= 100 cc
by: Murat Zor, et al.
Published: (2018-12-01)

TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy
by: Pirovano, G, et al.
Published: (2017)

Uji diagnostik prostate spesific antigen (PSA) pada keganasan prostat
by: , DAHESIHDEWI, Andaru, et al.
Published: (2002)

Predictors of Clinically Significant Prostate Cancer: A Comparative Study of PSA, PSA Density, and MRI Parameters
by: Mehmet Coşkun, et al.
Published: (2021-02-01)

Incidence of histological prostatitis and its correlation with PSA density
by: Affonso Celso Piovesan, et al.
Published: (2009-11-01)

Prostate Cancer Screening with PSA: Ten Years’ Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania
by: Ausvydas Patasius, et al.
Published: (2020-11-01)

Dynamics of Medical Screening: A Simulation Model of PSA Screening for Early Detection of Prostate Cancer
by: Özge Karanfil
Published: (2023-05-01)

Low hemoglobin and PSA kinetics are prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients
by: Yuji Hakozaki, et al.
Published: (2023-02-01)

Clinical application of p2PSA and its derivatives (%p2PSA and Phi) in the diagnosis of prostate cancer
by: Weiwang Cai, et al.
Published: (2023-11-01)

Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer
by: Bernhard Mlecnik, et al.
Published: (2023-01-01)

The Prognostic Value of Liquid Biopsies for Benefit of Salvage Radiotherapy in Relapsed Oligometastatic Prostate Cancer
by: Natalia V. Bogdanova, et al.
Published: (2022-08-01)